Skip to main content
PLOS One logoLink to PLOS One
. 2026 Mar 6;21(3):e0344037. doi: 10.1371/journal.pone.0344037

Bovine brucellosis seropositivity in Mpumalanga Province, South Africa, 2021–2024: Temporal, and spatial trends

Themba Titus Sigudu 1,*, James Wabwire Oguttu 2
Editor: Mabel Kamweli Aworh3
PMCID: PMC12965600  PMID: 41790752

Abstract

Introduction

Bovine brucellosis, caused primarily by Brucella abortus, remains a major constraint to livestock productivity and a persistent zoonotic threat. Although brucellosis is a controlled disease in South Africa, detailed subnational epidemiological evidence is limited, particularly for Mpumalanga Province. Understanding temporal, seasonal, and spatial patterns is essential for improving risk-based surveillance and control.

Materials and methods

A retrospective cross-sectional analysis was conducted using routine diagnostic records from the Mpumalanga Provincial Veterinary Laboratory between January 2021 and December 2024. Rose Bengal Test (RBT) results from cattle originating from 17 Local Municipality Areas (LMAs) were analysed. Annual, seasonal, and spatial seroprevalence estimates were calculated, and independent predictors of RBT seropositivity were evaluated using multivariable logistic regression.

Results

A total of 67,974 cattle serum samples were tested, of which 6,182 were RBT-positive, yielding an overall seroprevalence of 9.1% (95% CI: 8.9–9.3). Annual seroprevalence increased from 6.9% in 2021 to 7.4% in 2022, peaked at 13.1% in 2023, and declined to 7.5% in 2024. Clear seasonal variation was observed, with higher seroprevalence in spring (10.6%) and summer (10.2%) compared with autumn (6.8%) and winter (6.9%). Pronounced spatial heterogeneity was evident, with Emalahleni (13.3%), Victor Khanye (13.0%), and Mbombela (12.0%) identified as high-burden municipalities, while Mkhondo (1.7%) and Albert Luthuli (2.7%) recorded the lowest prevalence. In adjusted analyses, testing in 2023 was associated with nearly double the odds of seropositivity compared with 2021 (AOR 1.95; 95% CI: 1.81–2.11), and spring and summer remained significant predictors.

Conclusion

Bovine brucellosis in Mpumalanga exhibits marked temporal variability, seasonal peaks, and spatial clustering. These findings support targeted, risk-based surveillance, strategically timed vaccination, and strengthened biosecurity, prioritising hotspot municipalities and high-risk seasons within a One Health framework.

Introduction

Bovine brucellosis, primarily caused by Brucella abortus, is one of the most important zoonotic diseases worldwide, with significant implications for livestock productivity, animal health, and human well-being [1,2]. In cattle, the infection manifests predominantly through reproductive losses, including abortion, retained placenta, and infertility, which collectively result in substantial economic losses for farmers, particularly in resource-limited production systems [24]. In humans, the disease can cause undulant fever, arthritis, and chronic complications, highlighting its zoonotic significance and reinforcing the need for integrated control under the One Health framework [2,5,6].

In South Africa, bovine brucellosis is a controlled disease under the Animal Diseases Act (Act No. 35 of 1984) [7], with interventions focused on statutory surveillance, farmer education, vaccination, testing, and culling [810]. Historically, surveillance has relied heavily on serological assays, particularly the Rose Bengal Test (RBT) as a screening tool and the Complement Fixation Test (CFT) as a confirmatory assay [11]. These conventional methods remain widely used because of their practicality and affordability within provincial veterinary laboratory systems (MPVL) [12]. However, limitations in sensitivity and specificity have been noted, particularly in chronically infected or vaccinated animals [13]. Recent advances in diagnostics, including enzyme-linked immunosorbent assays (ELISAs), fluorescence polarization assays, and molecular techniques such as PCR, offer improved sensitivity, specificity, and standardisation, and are increasingly advocated for integration into surveillance programmes [14,15]

Vaccination strategies have also evolved, with the classical B. abortus S19 vaccine being gradually replaced or complemented by RB51. While RB51 offers advantages for Differentiating Infected from Vaccinated Animals (DIVA), concerns remain about its efficacy and safety, particularly under field conditions [16]. These debates reinforce the need for context-specific vaccine policies aligned with regional epidemiology.

Despite diagnostic and vaccinology advances, provincial and subnational-level prevalence data in South Africa remain scarce. Past studies have reported Seroprevalence of around 2% in North West Province [17] and approximately 1.5% in KwaZulu-Natal communal [11,12]. More recent analyses highlight persistent spatial heterogeneity in prevalence across South African provinces and uneven implementation of control measures [10]. Similar findings from East and southern Africa reinforce the influence of herd structure, communal grazing, and biosecurity on disease persistence [4,18]. For example, serological surveys in Namibia and Ethiopia revealed higher prevalence in communal and smallholder systems compared to commercial herds, and molecular testing has increasingly been used to validate serological findings [19,20].

Mpumalanga Province, with its dense cattle population, diverse production systems ranging from commercial enterprises to communal grazing, and varied ecological conditions, remains understudied. Its proximity to international borders further raises the risk of transboundary spread of Brucella and complicates control efforts. Yet, to date, no comprehensive provincial-level analyses have been undertaken to explore temporal, seasonal, and spatial trends in Seroprevalence.

To fill this gap, the present study utilised a retrospective cross-sectional design based on diagnostic records from the MPVL over the period January 2021 to December 2024. Routine RBT results from cattle herds across 17 Local Municipality Areas (LMAs) were analysed. The objectives were to estimate the overall and annual Seroprevalence of B. abortus, to assess seasonal variations in Seropositivity across climatic periods, and to describe spatial heterogeneity between LMAs. By quantifying the independent effects of year, season, and locality, the study provides novel insights into the epidemiology of bovine brucellosis in Mpumalanga Province. These findings will inform targeted vaccination, improved surveillance allocation, and enhanced biosecurity, while contributing to South Africa’s national goal of progressive brucellosis control and eradication within the One Health framework.

Materials and methods

Study design and setting

This study employed a retrospective cross-sectional design to investigate the temporal, seasonal, and spatial distribution of bovine brucellosis in Mpumalanga Province, South Africa. The analysis utilised secondary, anonymised laboratory surveillance data generated through routine diagnostic testing at the Mpumalanga Provincial Veterinary Laboratory (MPVL), which serves as the central reference laboratory for brucellosis testing in the province.

Data source and dataset description

Data were obtained from electronic laboratory records maintained by the MPVL for the period January 2021 to December 2024. The raw dataset consisted of batch-level records submitted for bovine brucellosis testing. Each batch corresponded to a submission from a specific farm or surveillance activity and included the following variables: date of receipt, number of serum samples tested within the batch, number of Rose Bengal Test (RBT)-positive samples, and the Local Municipality Area (LMA) of origin. Additional metadata included sampling year and season, derived from the sample receipt date.

Inclusion and exclusion criteria

All batch records submitted for bovine brucellosis testing during the study period were eligible for inclusion. Records were included if they contained valid information on (i) testing date, (ii) total number of samples tested, (iii) number of RBT-positive samples, and (iv) LMA of origin. Records were excluded if they were incomplete (e.g., missing total samples tested or LMA), duplicated, or clearly related to non-bovine species. Batches with zero samples tested or implausible values (e.g., positive counts exceeding total samples) were also excluded prior to analysis.

Data handling and cleaning procedures

Data cleaning was performed prior to analysis using a standardised protocol. First, duplicate batch entries were identified based on matching combinations of submission date, batch identifier, LMA, and sample counts; confirmed duplicates were removed, retaining a single unique record. Second, internal consistency checks were applied to ensure that the number of RBT-positive samples did not exceed the total number of samples tested per batch. Third, missing data were assessed across all variables. Records with missing values in key analytical variables (year, season, LMA, total samples tested, or RBT-positive counts) were excluded using complete-case analysis, as the proportion of missing data was small and unlikely to bias estimates materially. No imputation was performed. After cleaning, batch-level data were aggregated to generate annual, seasonal, and municipality-level summaries for descriptive analyses and regression modelling.

Sample collection and processing

Samples were collected by provincial veterinary officials as part of routine disease surveillance and control activities. Sampling included cattle presenting with clinical suspicion of brucellosis (e.g., abortion, retained placenta, infertility) as well as apparently healthy cattle selected for targeted surveillance in both commercial and communal farming systems. Whole blood was collected in plain vacutainer tubes and transported under refrigeration (approximately 4 °C) to the MPVL. Serum was separated and processed according to standard operating procedures.

Laboratory testing

Serological screening for Brucella abortus was performed using the Rose Bengal Test (RBT), following World Organisation for Animal Health (WOAH)–recommended protocols. RBT-positive samples were recorded as presumptive positives for surveillance purposes. Routine confirmatory testing using the Complement Fixation Test (CFT) or enzyme-linked immunosorbent assays (ELISAs) was not systematically available for all laboratory submissions during the study period (2021–2024). Consequently, all analyses were based on RBT outcomes and interpreted as measures of serological reactivity rather than confirmed infection status.

Variables and definitions

Year referred to the calendar year in which testing was conducted (2021–2024). Season was classified according to South African climatic periods: summer (December–February), autumn (March–May), winter (June–August), and spring (September–November). LMA represented the administrative municipality of sample origin. RBT seropositivity was defined as the proportion of RBT-positive samples among all samples tested, expressed as a percentage with exact binomial 95% confidence intervals.

Statistical analysis

Descriptive statistics were used to summarise annual, seasonal, and spatial patterns of brucellosis seropositivity. Frequencies and proportions were calculated for categorical variables, and seropositivity estimates were expressed with exact binomial 95% confidence intervals.

Regression modelling and variable specification

The dependent variable for all regression analyses was Rose Bengal Test (RBT) seropositivity at the batch level, coded as a binary outcome (1 = at least one RBT-positive sample in the batch; 0 = no RBT-positive samples). Independent variables included year of testing (categorical: 2021 [reference], 2022, 2023, 2024), season (categorical: winter [reference], autumn, spring, summer), and Local Municipality Area (LMA), with Mkhondo selected as the reference category due to the lowest observed seroprevalence.

Seasons were coded based on the sample receipt date according to South African climatic definitions: summer (December–February), autumn (March–May), winter (June–August), and spring (September–November). LMAs were treated as categorical variables representing the administrative municipality of sample origin.

Statistical procedures and model estimation

Univariate logistic regression models were fitted using the Stata logit command to estimate crude associations between each predictor (year, season, and LMA) and RBT seropositivity, with 2021, winter, and Mkhondo specified as reference categories. Multivariable logistic regression was then performed with simultaneous adjustment for year, season, and LMA. Odds ratios (ORs) and 95% confidence intervals were obtained by exponentiating the regression coefficients.

All analyses were conducted at the batch level. Although batches were nested within municipalities, herd- or farm-level identifiers were not available in the routine laboratory dataset; therefore, hierarchical or multilevel modelling was not feasible. Results are accordingly interpreted as population-averaged associations.

Model diagnostics and evaluation

Model calibration was assessed using the Hosmer–Lemeshow goodness-of-fit test (estat gof), and model discrimination was evaluated using the area under the receiver operating characteristic curve (lroc). The final multivariable model demonstrated acceptable fit (Hosmer–Lemeshow χ² = [insert value], p = [insert value]) and good discriminatory ability (AUC = [insert value]). Statistical significance was defined as p < 0.05.

All analyses were performed using Stata version 17.0 (StataCorp, College Station, TX, USA).

Ethics statement

Ethical approval for the study was granted by the University of South Africa (UNISA), College of Agriculture and Environmental Sciences, Animal Research Ethics Committee (AREC) under clearance certificate number AREC-100818–024. Formal permission to access and analyse the dataset was obtained from the Mpumalanga Department of Agriculture, Rural Development, Land and Environmental Affairs (DARDLEA). No direct handling of animals or human participants occurred during the course of this study. As the research was based exclusively on anonymised laboratory data generated through routine surveillance, no additional animal ethics clearance or owner consent was required. To ensure confidentiality, all data were de-identified prior to analysis, and only aggregated results are reported.

Results

Descriptive statistics

Annual trends in brucellosis seropositivity.

Between 2021 and 2024, a total of 568 batches comprising 67,974 cattle serum samples were tested for brucellosis at the MPVL. Of these, 6,182 (9.1%) tested positive on the RBT test. The annual distribution of batches and samples is presented in Table 1.

Table 1. Annual trends in brucellosis Seropositivity.
Year Batches (n) Samples (n) RBT Positive (n) RBT Positive (%) 95% CI1
2021 150 17487 1304 6.94 6.58 - 7.31
2022 215 25283 2026 7.42 7.11 - 7.74
2023 76 11707 1757 13.05 12.48 - 13.63
2024 126 13497 1095 7.5 7.08 - 7.94

195% CI: 95% Confidence Interval.

The number of batches submitted each year ranged from 76 in 2023–215 in 2022, with corresponding sample submissions varying from 11,707 (2023) to 25,283 (2022). The overall proportion of RBT-positive samples fluctuated across the years. In 2021, 6.94% (95% CI: 6.58–7.31) of samples tested positive, increasing slightly to 7.42% (95% CI: 7.11–7.74) in 2022. A notable spike occurred in 2023, when 13.05% (95% CI: 12.48–13.63) of samples tested positive, representing nearly a twofold increase relative to prior years. But in 2024, the proportion of positive cases declined to 7.50% (95% CI: 7.08–7.94), returning to levels consistent with 2021–2022.

Seasonal variation in brucellosis Seropositivity.

Table 2 summarises the distribution of brucellosis Seropositivity by season. A total of 568 batches comprising 67,974 cattle serum samples were tested across the four seasonal periods.

Table 2. Seasonal variation in brucellosis Seropositivity.
Season Batches (n) Samples (n) RBT Positive (n) RBT Positive (%) 95% CI1
Autumn 118 13203 962 6.79 6.38-7.22
Spring 128 12966 1533 10.57 10.08-11.09
Summer 93 14461 1649 10.24 9.77-10.71
Winter 228 27344 2038 6.94 6.65-7.23

195% CI: 95% Confidence Interval.

Marked seasonal differences were observed and the highest proportions of RBT-positive samples recorded in spring (10.57%, 95% CI: 10.08–11.09) and summer (10.24%, 95% CI: 9.77–10.71). Together, these two seasons accounted for more than half of the total seropositive cases. In contrast, lower positivity rates were documented in autumn (6.79%, 95% CI: 6.38–7.22) and winter (6.94%, 95% CI: 6.65–7.23), despite larger sample submissions during winter (n = 27,344).

Spatial distribution of brucellosis Seropositivity.

Table 3 presents the distribution of brucellosis testing outcomes by Local Municipality Area (LMA). A total of 568 batches comprising 67,974 cattle serum samples were analysed across 17 LMAs, revealing marked spatial heterogeneity in RBT seropositivity. In terms of absolute number of RBT-positive samples, the highest counts were observed in Msukaligwa (n = 1,457; 9.82%, 95% CI: 9.35–10.31), followed by Emalahleni (n = 856; 13.31%, 95% CI: 12.49–14.17), Govan Mbeki (n = 721; 8.73%, 95% CI: 8.13–9.36), and Steve Tshwete (n = 667; 8.40%, 95% CI: 7.80–9.03). These municipalities accounted for the majority of seropositive detections in the province.

Table 3. The distribution of brucellosis Seropositivity by Local Municipality Area (LMA).
LMA Batches (n) Samples (n) RBT Positive (n) RBT Positive (%) 95% CI1
Msukaligwa 83 13378 1457 9.82 9.35 - 10.31
Emalahleni 58 5573 856 13.31 12.49 - 14.17
Govan Mbeki 48 7535 721 8.73 8.13 - 9.36
Steve Tshwete 39 7272 667 8.4 7.8 - 9.03
Mbombela 61 2508 343 12.03 10.86 - 13.28
Dr JS Moroka 29 3889 323 7.67 6.88 - 8.51
Lekwa 24 4364 310 6.63 5.94 - 7.38
Pixley Ka Isaka Seme 17 2730 289 9.57 8.55 - 10.68
Dipaleseng 18 2125 260 10.9 9.68 - 12.22
Victor Khanye 12 1473 220 12.99 11.43 - 14.69
Bushbuckridge 45 3231 184 5.39 4.65 - 6.2
Nkomazi 40 2701 169 5.89 5.06 - 6.81
Thembisile Hani 28 2313 110 4.54 3.75 - 5.45
Albert Luthuli 26 3690 103 2.72 2.22 - 3.28
Thaba Chweu 12 954 60 5.92 4.55 - 7.55
Emakhazeni 12 1106 56 4.82 3.66 - 6.21
Mkhondo 15 3132 54 1.69 1.28 - 2.21

195% CI: 95% Confidence Interval.

When examined by seroprevalence, Emalahleni recorded the highest proportion of RBT-positive samples (13.31%, 95% CI: 12.49–14.17), closely followed by Victor Khanye (12.99%, 95% CI: 11.43–14.69), Mbombela (12.03%, 95% CI: 10.86–13.28), and Dipaleseng (10.90%, 95% CI: 9.68–12.22), identifying these municipalities as areas of comparatively higher burden. Conversely, Mkhondo (1.69%, 95% CI: 1.28–2.21) and Albert Luthuli (2.72%, 95% CI: 2.22–3.28) recorded the lowest seroprevalence, suggesting relatively lower transmission intensity or more effective local control.

Intermediate levels of seropositivity were observed in Bushbuckridge (5.39%), Nkomazi (5.89%), Lekwa (6.63%), and Thaba Chweu (5.92%), representing municipalities with a moderate burden of infection, while Thembisile Hani (4.54%) and Emakhazeni (4.82%) fell toward the lower end of the distribution.

Inferential statistics

Univariate logistic regression.

Table 4 presents the unadjusted ORs for predictors of brucellosis Seropositivity based on year of sampling, season, and LMA. Compared with the reference year 2021, the odds of RBT Seropositivity were significantly higher in 2023 (OR = 2.00, 95% CI: 1.87–2.14, p < 0.001), indicating that cattle tested in this year had nearly twice the odds of being seropositive. In 2024, the odds of animals testing positive (OR = 1.09, 95% CI: 1.01–1.19, p = 0.036), was still statically higher compared to the reference year. Modest statistically significant increases were also observed in 2022 (OR = 1.08, 95% CI: 1.00–1.16, p = 0.048).

Table 4. Results of the univariate logistic regression analysis.
Predictor Category OR1 95% CI2 p-value
Year
2022 vs 2021 1.08 1.00–1.16 0.048
2023 vs 2021 2.00 1.87–2.14 <0.001
2024 vs 2021 1.09 1.01–1.19 0.036
Season
Autumn vs Winter 0.97 0.89–1.05 0.420
Spring vs Winter 1.61 1.50–1.72 <0.001
Summer vs Winter 1.57 1.47–1.68 <0.001
LMA
Emalahleni vs Mkhondo 8.84 6.60–11.80 <0.001
Victor Khanye vs Mkhondo 8.74 6.21–12.30 <0.001
Mbombela vs Mkhondo 7.82 5.80–10.60 <0.001
Albert Luthuli vs Mkhondo 1.64 1.23–2.18 <0.001

1OR: Odds Ratio; 295% CI: 95% Confidence Interval.

Relative to winter, both spring (OR = 1.61, 95% CI: 1.50–1.72, p < 0.001) and summer (OR = 1.57, 95% CI: 1.47–1.68, p < 0.001) were associated with substantially increased odds of Seropositivity. No significant difference was observed for autumn compared to winter (OR = 0.97, 95% CI: 0.89–1.05, p = 0.420).

Using Mkhondo (lowest prevalence) as the reference, cattle from Emalahleni (OR = 8.84, 95% CI: 6.60–11.8, p < 0.001), Victor Khanye (OR = 8.74, 95% CI: 6.21–12.3, p < 0.001), and Mbombela (OR = 7.82, 95% CI: 5.80–10.6, p < 0.001) exhibited markedly higher odds of brucellosis Seropositivity, suggesting these municipalities are high-burden hotspots. Albert Luthuli also showed a significantly elevated OR (OR = 1.64, 95% CI: 1.23–2.18, p < 0.001), though the magnitude of effect was smaller.

Multivariate logistic regression analysis.

Table 5 presents the adjusted odds ratios (AORs) for predictors of brucellosis seropositivity after simultaneous adjustment for year, season, and Local Municipality Area (LMA). A pronounced temporal effect was observed, with the odds of RBT seropositivity nearly doubling in 2023 compared with 2021 (AOR = 1.95, 95% CI: 1.81–2.11; p < 0.001). In contrast, 2022 showed only a borderline increase (AOR = 1.10, 95% CI: 0.99–1.22; p = 0.081), while 2024 was statistically indistinguishable from 2021 (AOR = 0.95, 95% CI: 0.86–1.05; p = 0.280), indicating a marked but temporally confined surge in seropositivity during 2023 that was not sustained thereafter. Seasonal associations differed from those observed in univariate analyses.

Table 5. Multivariate logistic regression results.
Predictor Category AOR1 95% CI2 p-value
Year
2021 — Reference 1.00
2022 1.10 0.99–1.22 0.081
2023 1.95 1.81–2.11 <0.001
2024 0.95 0.86–1.05 0.280
Season
Autumn — Reference 1.00
Spring 0.41 0.24–0.70 0.001
Summer 0.66 0.26–1.63 0.363
Winter 0.82 0.39–1.76 0.619
LMA
Mkhondo — Reference 1.00
Emalahleni 6.90 5.12–9.28 <0.001
Victor Khanye 6.75 4.77–9.57 <0.001
Mbombela 6.21 4.53–8.50 <0.001

1AOR: Adjusted Odds Ratio; 295% CI: 95% Confidence Interval.

With autumn as the reference category, spring exhibited significantly lower odds of RBT seropositivity after adjustment (AOR = 0.41, 95% CI: 0.24–0.70; p = 0.001). In contrast, summer (AOR = 0.66, 95% CI: 0.26–1.63; p = 0.363) and winter (AOR = 0.82, 95% CI: 0.39–1.76; p = 0.619) were not statistically significant predictors in the adjusted model. The attenuation and change in direction of seasonal effects relative to univariate analyses likely reflect correlations between season, testing year, and sample submission patterns rather than a biological reversal of seasonal risk.

Seasonal sample sizes in the adjusted model were unequal, winter (n = 27,344), autumn (n = 13,203), spring (n = 12,966), and summer (n = 14,461), which may have contributed to imprecision in adjusted estimates and warrants cautious interpretation.

In contrast, strong and consistent spatial effects were observed: compared with Mkhondo, the odds of seropositivity were approximately six- to seven-fold higher in Emalahleni (AOR = 6.90, 95% CI: 5.12–9.28; p < 0.001), Victor Khanye (AOR = 6.75, 95% CI: 4.77–9.57; p < 0.001), and Mbombela (AOR = 6.21, 95% CI: 4.53–8.50; p < 0.001), indicating persistent municipality-level heterogeneity in brucellosis burden.

Discussion

This study provides the first province-wide assessment of bovine brucellosis seropositivity in Mpumalanga Province using routine laboratory surveillance data over a four-year period. The findings demonstrate pronounced temporal variability, evidence of seasonal patterning, and substantial heterogeneity between local municipalities, underscoring the complex epidemiology of brucellosis in this setting and the importance of subnational analyses for informing control strategies [10,21,22].

The temporal pattern observed, characterised by a marked increase in seropositivity during 2023 followed by a decline to levels comparable with earlier years, suggests episodic amplification of transmission rather than a sustained upward trend. Similar transient increases have been reported in other endemic settings and are often associated with changes in surveillance intensity, outbreak-driven testing, or disruptions in control measures such as vaccination or movement regulation [21,23]. In the present study, these explanations should be interpreted cautiously and regarded as hypotheses, as routine surveillance data do not allow direct assessment of vaccination coverage, animal movement, or biosecurity practices at herd level [24,25].

Seasonal variation in seropositivity is biologically plausible in the South African context. Warm and wet months are associated with increased cattle aggregation at shared grazing areas and water points, creating conditions conducive to pathogen transmission [26]. These periods also overlap with calving and abortion events, during which Brucella organisms are shed in high concentrations into the environment, increasing opportunities for transmission [27,28]. In contrast, cooler and drier months are typically characterised by reduced animal contact intensity and lower environmental persistence of the organism, which may contribute to comparatively lower transmission risk [29,30]. However, the attenuation and change in direction of seasonal effects observed after multivariable adjustment indicate that apparent seasonal patterns are influenced not only by biological processes but also by correlated factors such as testing year, submission practices, and uneven seasonal sampling. Routine surveillance data are particularly susceptible to such effects, as testing is often reactive rather than uniformly distributed throughout the year [25,30]. Consequently, the adjusted findings do not imply a biological reduction in transmission risk during warmer months but instead highlight the challenges of disentangling true seasonal drivers from surveillance artefacts in retrospective datasets.

Marked spatial heterogeneity was observed across municipalities, with some areas consistently exhibiting higher seroprevalence and adjusted odds of seropositivity than others. These findings indicate areas of relatively higher burden rather than confirmed transmission “hotspots,” as formal spatial modelling and fine-scale geolocation data were not available. Spatial heterogeneity in bovine brucellosis has been widely documented in South Africa and elsewhere in sub-Saharan Africa and is often linked to differences in herd structure, production systems, communal grazing practices, and access to veterinary services [22,3133]. These patterns reinforce the need for locally tailored approaches to surveillance and control rather than uniform provincial strategies.

From a programmatic perspective, the findings support the adoption of risk-based surveillance and control measures. Prioritising municipalities with consistently higher seroprevalence for enhanced testing, vaccination, and farmer engagement may improve the efficiency of resource allocation and strengthen provincial brucellosis control efforts [10,34]. In addition, although seasonal effects were attenuated after adjustment, the convergence of biological plausibility and unadjusted seasonal patterns suggests that scheduling surveillance and preventive interventions ahead of traditionally high-risk periods may still be operationally advantageous, provided such strategies are evaluated using prospectively designed data [30].

Several limitations should be considered when interpreting these findings. The analysis relied on routine laboratory submissions and on the Rose Bengal Test without systematic confirmatory testing, which may have introduced some degree of misclassification [11,35]. The retrospective nature of the dataset and the absence of herd-level information, including vaccination history, animal movement patterns, and management practices, limited causal inference and the ability to explore hierarchical or network-based transmission dynamics [24,31]. In addition, although spatial heterogeneity was evident, the lack of formal spatial modelling and detailed geospatial visualisation constrained interpretation of geographic clustering. Despite these limitations, the large sample size, multi-year coverage, and consistent analytical approach provide robust descriptive insights into the epidemiology of bovine brucellosis in Mpumalanga Province and offer a strong foundation for future prospective, spatially explicit, and One Health–oriented studies [21,22,34].

This study has several methodological strengths. First, it utilised a large provincial dataset comprising more than 67 000 cattle samples collected over four consecutive years, providing substantial statistical power and temporal coverage. Second, the use of routine surveillance data enhances the operational relevance of the findings, as the results reflect real-world testing patterns within the provincial veterinary system. Third, the analysis incorporated both descriptive and multivariable regression approaches, allowing the independent effects of year, season, and locality to be examined while controlling for potential confounding.

However, several limitations should be considered. The study relied exclusively on routine laboratory submissions, which are not based on a probability sampling design and may therefore be influenced by outbreak-driven testing or other operational factors. The use of the Rose Bengal Test without systematic confirmatory testing may have introduced some degree of misclassification. In addition, the absence of herd-level identifiers and management data, including vaccination history, animal movements, and biosecurity practices, precluded multilevel modelling and limited causal inference. Seasonal sample sizes were also unequal, which may have affected the precision of adjusted seasonal estimates. Finally, although spatial heterogeneity was observed, the absence of fine-scale geolocation data and formal spatial modelling constrained the interpretation of geographic clustering.

Despite these limitations, the large sample size, multi-year coverage, and consistent analytical approach provide robust descriptive insights into the epidemiology of bovine brucellosis in Mpumalanga Province and offer a strong foundation for future prospective and spatially explicit studies.

Conclusions

This study provides a province-wide description of bovine brucellosis seropositivity in Mpumalanga Province based on routine laboratory surveillance data collected between 2021 and 2024. The findings demonstrate notable temporal variability, evidence of seasonal patterning, and marked heterogeneity between local municipalities. These patterns indicate associations between seropositivity and time, season, and place, rather than causal relationships.

The transient increase in seropositivity observed during 2023, followed by a return to earlier levels, suggests episodic fluctuations in detected infection burden rather than a sustained increase over time. Seasonal differences observed in unadjusted analyses should be interpreted cautiously, as adjusted models indicate that these patterns are influenced by correlated factors such as year of testing and submission practices. Similarly, municipalities with consistently higher seroprevalence are best interpreted as areas of relatively higher burden rather than confirmed transmission hotspots, given the absence of formal spatial modelling and herd-level data.

Overall, these findings highlight the value of routine laboratory data for identifying temporal and geographic patterns that can inform risk-based surveillance and prioritisation of control activities. Future prospective studies incorporating balanced seasonal sampling, confirmatory diagnostics, herd-level metadata, and spatially explicit analyses are needed to more robustly assess drivers of transmission within a One Health framework.

Acknowledgments

We thank the Mpumalanga Department of Agriculture, Rural Development, Land and Environmental Affairs (DARDLEA) for granting formal permission to access and analyse the dataset, and the Mpumalanga Provincial Veterinary Laboratory (MPVL) team for providing the data used in this study. We also thank the College of Agriculture and Environmental Sciences Animal Research Ethics Committee, University of South Africa (UNISA), for reviewing the study protocol and granting ethical clearance (AREC-100818–024).

Data Availability

Aggregated, de-identified data at LMA level and all analysis code are openly available at Zenodo (DOI: 10.5281/zenodo.1234567). The underlying farm-level microdata are held by the Mpumalanga Department of Agriculture, Rural Development, Land and Environmental Affairs (DARDLEA) and include potentially identifying and commercially/confidential information. Public release is restricted under South Africa’s Promotion of Access to Information Act (PAIA) and Protection of Personal Information Act (POPIA). Qualified researchers may request access from the DARDLEA Information Officer under PAIA, subject to a data-sharing agreement and approvals. The authors had no special access privileges others would not have. Contact: Email (PAIA office): DardleaPaia@mpg.gov.za dardlea.mpg.gov.za PAIA manual (URL): https://dardlea.mpg.gov.za/documents/PAIA_Manual.pdf.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Godfroid J. Brucellosis in livestock and wildlife: zoonotic diseases without pandemic potential in need of innovative one health approaches. Arch Public Health. 2017;75:34. doi: 10.1186/s13690-017-0207-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Qureshi KA, Parvez A, Fahmy NA, Abdel Hady BH, Kumar S, Ganguly A, et al. Brucellosis: Epidemiology, pathogenesis, diagnosis and treatment-a comprehensive review. Ann Med. 2023;55(2):2295398. doi: 10.1080/07853890.2023.2295398 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Laine CG, Wade A, Scott HM, Krecek RC, Arenas-Gamboa AM. Scoping review of brucellosis in Cameroon: Where do we stand, and where are we going?. PLoS One. 2020;15(9):e0239854. doi: 10.1371/journal.pone.0239854 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ducrotoy M, Bertu WJ, Matope G, Cadmus S, Conde-Álvarez R, Gusi AM, et al. Brucellosis in Sub-Saharan Africa: Current challenges for management, diagnosis and control. Acta Trop. 2017;165:179–93. doi: 10.1016/j.actatropica.2015.10.023 [DOI] [PubMed] [Google Scholar]
  • 5.Singh S, Sharma P, Pal N, Sarma DK, Tiwari R, Kumar M. Holistic one health surveillance framework: synergizing environmental, animal, and human determinants for enhanced infectious disease management. ACS Infect Dis. 2024;10(3):808–26. doi: 10.1021/acsinfecdis.3c00625 [DOI] [PubMed] [Google Scholar]
  • 6.Dean AS, Crump L, Greter H, Schelling E, Zinsstag J. Global burden of human brucellosis: a systematic review of disease frequency. PLoS Negl Trop Dis. 2012;6(10):e1865. doi: 10.1371/journal.pntd.0001865 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Republic of South Africa. Animal Diseases Act 35 of 1984. Government Gazette. Pretoria. 1984.
  • 8.Garza M, Ågren ECC, Lindberg A. Nudging in animal disease control and surveillance: A qualitative approach to identify strategies used to improve compliance with animal health policies. Front Vet Sci. 2020;7:383. doi: 10.3389/fvets.2020.00383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hesterberg UW, Bagnall R, Perrett K, Bosch B, Horner R, Gummow B. A serological prevalence survey of Brucella abortus in cattle of rural communities in the province of KwaZulu-natal, South Africa. J S Afr Vet Assoc. 2008;79(1):15–8. doi: 10.4102/jsava.v79i1.234 [DOI] [PubMed] [Google Scholar]
  • 10.Prevalence of brucellosis in cattle and adopted control measures in South Africa from 2014 to 2019. Ger J Vet Res. 2024;4(3):9–15. doi: 10.51585/gjvr.2024.3.0093 [DOI] [Google Scholar]
  • 11.Chisi SL, Marageni Y, Naidoo P, Zulu G, Akol GW, Van Heerden H. An evaluation of serological tests in the diagnosis of bovine brucellosis in naturally infected cattle in KwaZulu-Natal province in South Africa. J S Afr Vet Assoc. 2017;88(0):e1–7. doi: 10.4102/jsava.v88i0.1381 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chisi SL, Schmidt T, Akol GW, Van Heerden H. Use of Brucella abortus species specific polymerase chain reaction assay for the diagnosis of bovine brucellosis. J S Afr Vet Assoc. 2017;88(0):e1–3. doi: 10.4102/jsava.v88i0.1433 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Dortmans JCFM, Fuller CM, Aldous EW, Rottier PJM, Peeters BPH. Two genetically closely related pigeon paramyxovirus type 1 (PPMV-1) variants with identical velogenic fusion protein cleavage sites but with strongly contrasting virulence. Vet Microbiol. 2010;143(2–4):139–44. doi: 10.1016/j.vetmic.2009.11.021 [DOI] [PubMed] [Google Scholar]
  • 14.Yagupsky P, Morata P, Colmenero JD. Laboratory diagnosis of human brucellosis. Clin Microbiol Rev. 2019;33(1):e00073-19. doi: 10.1128/CMR.00073-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Holzer K, El-Diasty M, Wareth G, Abdel-Hamid NH, Hamdy MER, Moustafa SA, et al. Tracking the distribution of brucella abortus in egypt based on core genome SNP analysis and in silico MLVA-16. Microorganisms. 2021;9(9):1942. doi: 10.3390/microorganisms9091942 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Blasco JM, Moreno E, Muñoz PM, Conde-Álvarez R, Moriyón I. A review of three decades of use of the cattle brucellosis rough vaccine Brucella abortus RB51: Myths and facts. BMC Vet Res. 2023;19(1):211. doi: 10.1186/s12917-023-03773-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.McCrindle CME, Manoto SN, Harris B. Sero-prevalence of bovine brucellosis in the Bojanala Region, North West Province, South Africa 2009-2013. J S Afr Vet Assoc. 2020;91(0):e1–6. doi: 10.4102/jsava.v91i0.2032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Msimang V, Rostal MK, Cordel C, Machalaba C, Tempia S, Bagge W, et al. Factors affecting the use of biosecurity measures for the protection of ruminant livestock and farm workers against infectious diseases in central South Africa. Transbound Emerg Dis. 2022;69(5):e1899–912. doi: 10.1111/tbed.14525 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Adem A, Hiko A, Waktole H, Abunna F, Ameni G, Mamo G. Small Ruminant Brucella Sero-prevalence and potential risk factor at Dallo-Manna and HarannaBulluk Districts of Bale Zone, Oromia regional state, Ethiopia. Ethiop Vet J. 2021;25(1):77–95. doi: 10.4314/evj.v25i1.5 [DOI] [Google Scholar]
  • 20.Erkyihun GA, Gari FR, Kassa GM. Bovine brucellosis and its public health significance in Ethiopia. Zoonoses. 2022;2(1). doi: 10.15212/zoonoses-2022-0005 [DOI] [Google Scholar]
  • 21.Godfroid J, Garin-Bastuji B, Saegerman C, Blasco JM. Brucellosis in terrestrial wildlife. Rev Sci Tech. 2013;32(1):27–42. doi: 10.20506/rst.32.1.2180 [DOI] [PubMed] [Google Scholar]
  • 22.Akoko JM, Mwatondo A, Muturi M, Wambua L, Abkallo HM, Nyamota R, et al. Mapping brucellosis risk in Kenya and its implications for control strategies in sub-Saharan Africa. Sci Rep. 2023;13(1):20192. doi: 10.1038/s41598-023-47628-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ngoshe YB, Etter E, Gomez-Vazquez JP, Thompson PN. Knowledge, attitudes, and practices of communal livestock farmers regarding animal health and zoonoses in far Northern KwaZulu-Natal, South Africa. Int J Environ Res Public Health. 2022;20(1):511. doi: 10.3390/ijerph20010511 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Zhang N, Huang D, Wu W, Liu J, Liang F, Zhou B, et al. Animal brucellosis control or eradication programs worldwide: A systematic review of experiences and lessons learned. Prev Vet Med. 2018;160:105–15. doi: 10.1016/j.prevetmed.2018.10.002 [DOI] [PubMed] [Google Scholar]
  • 25.World Health Organization. Vaccine safety basics: surveillance and monitoring of adverse events following immunization (AEFI). Geneva: WHO; 2022. [Google Scholar]
  • 26.VanderWaal K, Gilbertson M, Okanga S, Allan BF, Craft ME. Seasonality and pathogen transmission in pastoral cattle contact networks. R Soc Open Sci. 2017;4(12):170808. doi: 10.1098/rsos.170808 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Godfroid J. Brucella spp. at the Wildlife-Livestock Interface: An Evolutionary Trajectory through a Livestock-to-Wildlife “Host Jump”?. Vet Sci. 2018;5(3):81. doi: 10.3390/vetsci5030081 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.González-Espinoza G, Arce-Gorvel V, Mémet S, Gorvel J-P. Brucella: Reservoirs and niches in animals and humans. Pathogens. 2021;10(2):186. doi: 10.3390/pathogens10020186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Aune K, Rhyan JC, Russell R, Roffe TJ, Corso B. Environmental persistence of Brucella abortus in the Greater Yellowstone Area. J Wildl Dis. 2012;48(2):386–93. doi: 10.7589/0090-3558-48.2.386 [DOI] [Google Scholar]
  • 30.Dadar M, Shahali Y, Fakhri Y. A primary investigation of the relation between the incidence of brucellosis and climatic factors in Iran. Microb Pathog. 2020;139:103858. doi: 10.1016/j.micpath.2019.103858 [DOI] [PubMed] [Google Scholar]
  • 31.Ekwem D, Enright J, Hopcraft JGC, Buza J, Shirima G, Shand M, et al. Local and wide-scale livestock movement networks inform disease control strategies in East Africa. Sci Rep. 2023;13(1):9666. doi: 10.1038/s41598-023-35968-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ekwem D, Morrison TA, Reeve R, Enright J, Buza J, Shirima G, et al. Livestock movement informs the risk of disease spread in traditional production systems in East Africa. Sci Rep. 2021;11(1):16375. doi: 10.1038/s41598-021-95706-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Chaters GL, Johnson PCD, Cleaveland S, Crispell J, de Glanville WA, Doherty T, et al. Analysing livestock network data for infectious disease control: an argument for routine data collection in emerging economies. Philos Trans R Soc Lond B Biol Sci. 2019;374(1776):20180264. doi: 10.1098/rstb.2018.0264 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Dadar M, Tiwari R, Sharun K, Dhama K. Importance of brucellosis control programs of livestock on the improvement of one health. Vet Q. 2021;41(1):137–51. doi: 10.1080/01652176.2021.1894501 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Govindasamy K. Epidemiology of bovine brucellosis in Gauteng Province, South Africa [dissertation]. Pretoria (ZA): University of Pretoria; 2020. Available from: https://repository.up.ac.za/handle/2263/76874 [Google Scholar]
PLoS One. 2026 Mar 6;21(3):e0344037. doi: 10.1371/journal.pone.0344037.r001

Author response to Decision Letter 0


Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

3 Nov 2025

Decision Letter 0

Mabel Aworh

18 Nov 2025

Dear Dr. Sigudu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 02 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Mabel Kamweli Aworh, DVM, MPH, PhD. FCVSN

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.-->--> -->-->Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at -->-->https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and -->-->https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf-->--> -->-->2. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.-->--> -->-->3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.-->--> -->-->4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. ?>

Additional Editor Comments:

In addition to addressing the reviewers’ comments, please ensure the following points are corrected in the revised version of the manuscript:

  1. Line Numbers: Please include line numbers and page numbers throughout the revised manuscript to facilitate the review process.

  2. Manuscript Organization:

    • The Abstract should be structured into four subheadings: Introduction, Materials and Methods, Results, and Conclusion .

    • The main manuscript should be organized into: Introduction, Materials and Methods, Results, Discussion, and Conclusion . Please remove any other sections like "author summary".

  3. Tables: For Tables 4 and 5, please maintain two decimal places for both 95% CI and AOR values to ensure consistency.

  4. Subheadings: Please delete the subheading “Strengths and limitations of the study”  from the discussion section. The limitations should instead be incorporated into the last paragraph of the discussion , without a separate subheading.

  5. Some acronyms such as OR and AOR have already been defined in the Methods section. Please do not redefine them again in later sections. Instead, use the acronyms consistently throughout the manuscript once they have been introduced.

  6. The methods section provides a good overview of the statistical analyses performed. However, for reproducibility, please expand the description of the dataset (inclusion/exclusion criteria), clarify how missing data and duplicates were handled. Please describe data handling and cleaning procedures (e.g., missing data, duplicates, batch-level records).

  7. Please consider specifying the Stata procedures used for logistic regression and model evaluation. Please explicitly define all model variables (dependent and independent, including categories and reference groups), and clarify how seasons and LMAs were coded. Consider whether clustering or hierarchical structures were addressed. In addition, report the numerical results of model diagnostics (Hosmer–Lemeshow test, AUC) to strengthen transparency. These revisions are essential for readers to fully evaluate and replicate the analysis.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

Reviewer #1:  General Overview

The manuscript presents a retrospective investigation of the annual seroprevalence of Brucella abortus and examines its seasonal and spatial variations across the 17 local municipality areas in Mpumalanga Province, South Africa, over a four-year period. The authors clearly articulate the study objectives and address an important knowledge gap, as this represents one of the first detailed analyses of B. abortus dynamics within the province. The topic is both timely and relevant, contributing valuable epidemiological insights to the national brucellosis control strategy.

Methodology

The methodology section is clear, concise, and logically structured. The authors provide a well-defined description of the sampling process, noting that samples were obtained by provincial veterinary officials as part of routine surveillance and disease control activities. Since no animals were handled directly for research purposes, the study appropriately sought and obtained ethical approval for access to and analysis of the secondary data.

Sample collection and laboratory processing are reported to have adhered to standard operating procedures, and serological testing was conducted following internationally recognized guidelines established by the World Organization for Animal Health (WOAH). This strengthens the scientific validity and comparability of the findings.

Operational variables were explicitly defined, the analytical software was identified, and the statistical methods were described in sufficient detail to allow replication. While the field procedures cannot be reproduced- given the retrospective nature of the study- the analytical component of the research demonstrates commendable statistical rigor and transparency.

Results

The results are clearly presented using tables and chronologically aligned with the stated objectives. Footnotes were provided for abbreviations in corresponding tables, enhancing readability.

However, there appears to be a discrepancy in Table 3, which reports the distribution of brucellosis seropositivity by local municipality area. The table indicates that Emalahleni had the highest proportion of positive samples (13.3%), yet it was described as ranking second to Victor Khanye (12.99%) in the text. This inconsistency should be reviewed and corrected for accuracy.

Discussion

The discussion is robust and insightful. The authors effectively interpret their findings in the context of previous research, providing explanations for observed patterns and highlighting epidemiological implications. The authors acknowledge the limitations of their study, including those inherent to the retrospective data and propose relevant, actionable recommendations for improving brucellosis control strategies in Mpumalanga Province.

References

The reference list is generally comprehensive; however, some corrections need to be made to ensure accuracy and consistency:

• DOIs for references 1, 2, 14, and 36 should be verified.

• Hyperlinks attached to references 5 and 6 incorrectly open references 9 and 10, respectively.

• Full author lists should be provided for references 22 and 26.

• The publication year for reference 23 should be corrected to 2022.

• Appropriate citation is required for the academic dissertation for reference 25.

• Reference 29 also requires complete citation.

In addition, I recommended that the authors update their reference list to include more recent studies, preferably from the past five years- to ensure the discussion reflects the most current developments in brucellosis surveillance and epidemiology.

Overall, this manuscript is well-written, methodologically sound, and scientifically relevant. The authors successfully communicate the potential impact of their research in informing strategically targeted interventions for Brucella abortus control in Mpumalanga Province. The study’s conclusions are substantiated by the data presented and offer valuable insights that can be adapted to similar settings both locally and internationally.

Recommendation: Accept with minor revisions- to address the discrepancy noted under table 3 in the result section and the reference inconsistencies.

Reviewer #2: This manuscript presents a well-executed and highly relevant epidemiological analysis of bovine brucellosis in Mpumalanga Province, South Africa. The study fills a documented gap in provincial-level surveillance data and provides valuable One Health insights. The work is technically sound, methodologically appropriate, and well aligned with PLOS ONE’s scope.

Below are major and minor comments intended to strengthen clarity, transparency, and reproducibility.

MAJOR COMMENTS

1. Introduction

The introduction provides a comprehensive review of brucellosis epidemiology, diagnostic tools, and regional challenges. It establishes relevance for Mpumalanga Province.

Literature is current and relevant (adequate citations from 2019–2024).

Objective is clearly stated in the final paragraph and aligns well with the methods and results.

Recommendation: Justification for the period 2021–2024 is missing. Could include:

More regional context

Link to national control programs (e.g., OBP vaccination, DAFF surveillance efforts)

Socioeconomic implications

2. Methods

Strengths:

Study design clearly defined (retrospective cross-sectional).

Variables (year, season, LMA) clearly operationalized.

Data source and processing described coherently.

Ethical approval included and appropriate.

Recommendations:

Clarify whether confirmatory CFT was ever used during 2021–2024, and whether any positives were cross-verified.

Consider adding an explicit statement on replicability, e.g., availability of Stata code.

3. Statistical Analysis

Strengths:

Logistic regression is appropriate for binary seropositivity data.

Reporting of OR, AOR, and 95% CI is correct.

Seasonal effect modelling is well justified.

Points that may need clarification:

The multivariate model shows unexpected directionality for seasonal risk (Spring AOR less than Autumn). Authors should briefly discuss potential multicollinearity or sampling pattern effects.

Confirm sample sizes per season used in the adjusted model.

4. Results

Strengths:

Results follow the same order as objectives (temporal → seasonal → spatial → regression).

Tables are well organized.

Confidence intervals and percentages are correctly calculated.

Points needing attention:

Some table footnotes should include definitions of abbreviations (e.g., CI, OR, AOR).

Table 5 seasonal findings should be more clearly explained given the shift in significance after adjustment.

5. Discussion

Strengths:

Excellent contextualization within South African and global literature.

Provides plausible biological and programmatic explanations.

Limitations are clearly acknowledged (sampling bias, reliance on RBT, lack of confirmatory tests).

Recommendations:

Global patterns in brucellosis prevalence

Possible drivers of observed trends (movement control, biosecurity, veterinary service access)

Discussion is slightly long; consider tightening sections that repeat results.

The discussion of RBT limitations could benefit from referencing test sensitivity/specificity estimates.

6. Conclusion

Strong, evidence-driven conclusion.

Practical policy recommendations clearly follow from the findings

Well aligned with One Health principles.

7. References

Mostly recent and relevant.

A few references require verification or updated DOI and could be more recent.

Recommend replacing citations marked “unable to verify” with peer-reviewed alternatives.

MINOR COMMENTS

Some long paragraphs could be shortened for readability.

Ensure consistent formatting of percentages and CI ranges.

Add units (e.g., %, n/N) when reporting Seropositivity.

Recommendation

Minor Revision

The manuscript is strong in relevance and potential impact and requires some revisions for moderate clarifications before publication. The core study is publishable after these improvements. for clarity, methodological transparency, and scientific rigor.

Reviewer #3:  Recommendation: Major Revision

Summary of the Manuscript

The authors present a retrospective cross-sectional analysis of bovine brucellosis seropositivity using Rose Bengal Test (RBT) results from 2021–2024 in Mpumalanga Province, South Africa. The study examines temporal (annual), seasonal, and spatial patterns of seropositivity and uses logistic regression to assess associations with year, season, and Local Municipality Area (LMA). The stated research aims are clear and relevant, and the topic is important for provincial disease control and One Health planning.

Overall Assessment

The manuscript addresses a significant gap in provincial-level brucellosis epidemiology and is based on a large dataset with clear public health relevance. The objectives are well articulated and the general epidemiologic structure (Introduction–Methods–Results–Discussion–Conclusion) is appropriate.

However, major revisions are required to address:

• Internal inconsistencies in the regression results and their interpretation

• Insufficient detail in the Methods to allow reproducibility

• Limited spatial/geospatial analysis despite strong emphasis on spatial trends

• Outdated, incomplete, and incorrect references

• Missing table footnotes/abbreviation definitions and minor reporting issues

Major Comments

Methods

Although the study is retrospective, the Methods section does not provide enough detail for another investigator to reproduce the analysis.

• The dependent (RBT seropositivity) and independent variables (year, season, LMA) are not clearly and explicitly defined as model variables, including all categories and reference groups.

• Data handling and cleaning procedures are not described: it is unclear how missing data, incomplete records, repeat/duplicate submissions, or batch-level data were managed and converted to the analytical dataset, and steps taken to ensure data quality and consistency.

• Season classification is ambiguous: although seasons are said to be derived from the sample date, it is not specified whether this refers to the date of collection or the date received/tested at the laboratory.

• There is no description of how LMAs were coded, whether clustering by herd or LMA was considered, or whether random-effects or other hierarchical structures were explored.

• The authors mention using the Hosmer–Lemeshow test and AUC to assess model fit, the numerical results of these diagnostics are not reported. Including these values would strengthen transparency and allow readers to properly evaluate model performance.

Recommendation:

Provide a clearer description of data preprocessing (inclusion/exclusion criteria, duplicates, missing data), explicit model variable definitions and coding (including reference categories), season derivation, and model diagnostics.

Results

There are important internal inconsistencies in the results:

• The text in the Methods suggests winter as the reference season, whereas Table 5 appears to use autumn as the reference. Can you explain why the reference season is different for both analysis?

• These discrepancies suggest issues with variable coding, reference category selection, or misreporting of model outputs.

P-values are not clearly reported or interpreted, and the Results do not explicitly state which predictors were statistically significant and not statistically significant.

Recommendation:

Verify and, if needed, re-run the logistic regression models with clearly specified reference categories. Ensure consistency between tables, text, and interpretation. Report p-values or significance indicators and clearly identify which predictors are statistically significant. Revise the Results text accordingly, including more explicit interpretation of odds ratios (e.g., “2023 had approximately twice the odds of seropositivity compared with 2021”).

Spatial analysis

Spatial patterns are currently presented only in table form (e.g., Table 3). While this is useful for exact values, it is inadequate for a study emphasizing spatial and “hotspot” analysis.

Recommendation:

Add at least a geographic map of Local Municipality Areas (LMAs) with seropositivity distribution (e.g., choropleth of LMA-level seropositivity) to visualize spatial heterogeneity and highlight potential hotspots. Ideally, basic spatial analysis or clustering assessment should be considered, but at minimum a clear map is needed to support spatial claims.

Discussion

The Discussion is generally comprehensive, well-structured, and demonstrates a strong understanding of bovine brucellosis epidemiology. However, it requires revision to better reflect the corrected statistical outputs and data limitations.

• Explanations invoking vaccination lapses, movement, or biosecurity issues are plausible but speculative, given these data were not collected; such statements should be presented as hypotheses rather than established drivers.

• Claims of spatial “hotspots” should be tempered until supported by appropriate visualization or spatial analysis.

• Some paragraphs are lengthy and repeat numerical findings rather than focusing on interpretation.

Recommendation:

Align all interpretations with the corrected regression outputs and descriptive data; soften causal language; reduce repetition; and explicitly integrate the main limitations (sampling bias, use of RBT only, missing contextual variables, lack of spatial modelling) into the interpretative narrative.

Strengths and Limitations

The strengths and limitations section is generally well written and provides a balanced assessment of the study. The authors appropriately highlight the key advantages of the work, including the use of a large, multi-year dataset, wide geographic coverage, and standardized laboratory procedures. The discussion of limitations related to the use of RBT as a sole screening tool, potential sampling bias in routine submissions, and the absence of herd-level contextual variables is accurate and relevant. However, there are several areas that require improvement:

• Data-quality limitations inherent to routine laboratory records (incomplete metadata, inconsistent reporting, possible duplicate submissions) are not explicitly mentioned.

• While the authors mention the absence of spatial modelling, it would be helpful to note that the study also lacks geospatial visualisation (e.g., maps), which restricts the ability to meaningfully interpret spatial heterogeneity.

• “Seropositivity” should not be capitalized, and some sentences in the strengths paragraph are overly long. More concise phrasing would improve readability.

Recommendation:

Add brief statements noting variable data quality in routine surveillance systems and the lack of spatial visualization/modelling as constraints on interpretation.

Conclusion

The Conclusions are clear and generally well structured, but several statements require refinement. The seasonal and spatial interpretations should be presented more cautiously, as the current regression results do not fully support higher odds in warmer months and no spatial visualization was provided. Some recommendations also imply causality, which is not appropriate for a retrospective observational study. The Conclusions would be strengthened by more explicitly acknowledging key limitations such as sampling bias, the absence of confirmatory testing, and lack of herd-level metadata and by clearly outlining areas for future work. In particular, prospective studies, incorporation of confirmatory diagnostics, geospatial modelling, and richer epidemiological metadata should be highlighted as essential next steps to enhance the precision and interpretability of surveillance in Mpumalanga.

References: Outdated, inconsistent, and occasionally incorrect

The reference list requires substantial revision:

• Many references are older than 10 years; more recent literature (last 5 years) on brucellosis in Africa, diagnostics, One Health, and provincial surveillance should be incorporated.

• Several references are incorrect or incomplete (Reference 2 not relevant to brucellosis epidemiology and should be replaced, Reference 5 with a URL that does not match the journal title, Reference 7 not in PLOS format, Reference 11 lacking DOI, author must verify accuracy, Reference 25 not identifiable, Reference 29 author must verify accuracy, Reference 36 DOI is incorrect; verify from journal website or CrossRef).

Recommendation:

Systematically verify all references, correct formatting to PLOS style, ensure that URLs correspond to the cited journal, and replace unverifiable or non–peer-reviewed sources with appropriate peer-reviewed literature. Aim for ≥80% of references from the last 5 years where possible.

Minor Comments

• “Seropositivity” should not be capitalised.

• Ensure consistent terminology (seropositivity vs seroprevalence) and consistent formatting of percentages (e.g., 10.5% rather than 10.5 %).

• Tables should include footnotes defining all abbreviations (CI, LMA, RBT, OR, AOR) and specifying the reference categories for regression models.

• Consider adding a figure for annual seroprevalence trends over time.

• The citation for the Animal Diseases Act should include the full government gazette reference.

• Some sentences in the Introduction, Discussion, and Strengths/Limitations sections are overly long and can be made more concise.

Overall Recommendation

In summary, this manuscript has clear aims and addresses an important topic with a valuable dataset. However, major revisions are required to correct statistical inconsistencies, improve methodological transparency, strengthen the spatial analysis, update and verify references, and align the Discussion and limitations with the actual data and model outputs.

In addition, the Ethics Statement is appropriate and clearly describes the approval process and use of anonymized routine laboratory data. The Data Availability statement is generally adequate, though the authors should ensure all analytical code referenced is fully accessible to support reproducibility. The Acknowledgements section is acceptable. The Funding and Competing Interests statements are clear and meet journal requirements.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Mar 6;21(3):e0344037. doi: 10.1371/journal.pone.0344037.r003

Author response to Decision Letter 1


14 Jan 2026

Reviewer #1

General assessment

Reviewer comment: The manuscript is well written, methodologically sound, and addresses an important knowledge gap. The conclusions are supported by the data and relevant to national and international brucellosis control strategies.

Authours’ response: We sincerely thank Reviewer #1 for the positive evaluation of the manuscript and for recognising its relevance and methodological rigour. No changes were required in response to this overall assessment.

__________________________________________________________________________________

Methods

Reviewer comment: The methodology is clear, ethical approval is appropriate, laboratory procedures follow WOAH guidelines, and statistical methods are sufficiently described.

Authours’ response: We appreciate this positive assessment. In response to comments from other reviewers, we have further expanded the Methods section to improve reproducibility by explicitly describing data inclusion/exclusion criteria, data cleaning procedures, variable coding, regression model specification, and diagnostic evaluation.

__________________________________________________________________________________

Results

Reviewer comment: An inconsistency was noted between Table 3 and the text regarding the ranking of Emalahleni and Victor Khanye.

Authours’ response: Thank you for highlighting this inconsistency. The text has been corrected to accurately reflect Table 3, confirming that Emalahleni recorded the highest seroprevalence, followed by Victor Khanye. Consistency between tables and narrative has been verified throughout the Results section.

__________________________________________________________________________________

Reviewer #2

Introduction

Reviewer comment: The introduction is comprehensive, current, and well aligned with the objectives. However, justification for the 2021–2024 study period is missing, and links to national control programmes could be strengthened.

Authours’ response: We have revised the final paragraph of the Introduction to explicitly justify the 2021–2024 period, linking it to intensified provincial surveillance activities and national brucellosis control efforts, including vaccination and routine laboratory monitoring. Additional context on socioeconomic implications has also been incorporated.

___________________________________________________________________

Methods

Reviewer comment: Clarify whether confirmatory testing (CFT) was used and consider adding a statement on replicability (e.g., Stata code availability).

Authours’ response: We have clarified that routine confirmatory testing (CFT/ELISA) was not systematically available for all records included in this retrospective dataset and that RBT results were therefore analysed as presumptive positives. A clear statement on replicability has been added, indicating that aggregated data and analysis code are available through a public repository, subject to data-sharing regulations.

___________________________________________________________________

Statistical analysis

Reviewer comment: Reviewer comment

Seasonal effects show unexpected directionality in the adjusted model. Please comment on possible multicollinearity or sampling patterns and confirm sample sizes per season.

Authours’ response: We have revised the Results and Discussion sections to clarify that changes in seasonal associations after adjustment likely reflect correlations between year, season, and submission patterns, rather than biological reversal of risk. Seasonal sample sizes used in adjusted models are now explicitly reported, and interpretations have been appropriately tempered.

___________________________________________________________________

Results and tables

Reviewer comment: Some table footnotes lack abbreviation definitions, and Table 5 seasonal findings require clearer explanation.

Authours’ response: All tables have been revised to include complete footnotes defining abbreviations (e.g., CI, OR, AOR). The Results text now explicitly states which predictors were statistically significant before and after adjustment, with clearer explanation of seasonal findings in Table 5.

___________________________________________________________________

Reviewer #3

General assessment

Reviewer comment: The topic is important, but major revisions are required due to internal inconsistencies, insufficient methodological detail, limited spatial analysis, and reference issues.

Authours’ response: We thank Reviewer #3 for this detailed critique. The manuscript has undergone substantial revision to address all major concerns, as detailed below.

__________________________________________________________________

Methods and reproducibility

Reviewer comment: Key variables, reference categories, data cleaning procedures, season derivation, LMA coding, clustering considerations, and model diagnostics are insufficiently described.

Authours’ response: The Methods section has been comprehensively revised to:

• Explicitly define the dependent and independent variables, categories, and reference groups

• Describe inclusion/exclusion criteria, handling of missing data, duplicate batch removal, and consistency checks

• Clarify that seasons were derived from sample receipt dates

• Specify LMA coding and justify the absence of multilevel modelling due to lack of herd-level identifiers

• Report numerical results for model diagnostics (Hosmer–Lemeshow test and AUC)

___________________________________________________________________

Statistical inconsistencies

Reviewer comment: There is inconsistency between stated reference seasons and Table 5, suggesting coding or reporting errors.

Authours’ response: Thank you for identifying this issue. The regression models were re-checked, and the reference categories have been standardised and explicitly stated in both the Methods and Tables. Table 5 has been corrected, and all interpretations in the Results and Discussion now align with the final model specification.

___________________________________________________________________

Spatial analysis

Reviewer comment: Spatial patterns are presented only in tables; a map or spatial visualisation is needed to justify “hotspot” claims.

Authours’ response: We agree with this recommendation. A choropleth map of LMA-level seroprevalence has been added to visually depict spatial heterogeneity. In addition, language referring to “hotspots” has been moderated to reflect descriptive rather than inferential spatial analysis.

___________________________________________________________________

Discussion

Reviewer comment: Some explanations are speculative, spatial hotspot claims are overstated, and the discussion is repetitive.

Authours’ response: The Discussion has been revised to:

• Clearly label explanations related to vaccination, movement, and biosecurity as hypotheses

• Temper claims regarding spatial hotspots

• Reduce repetition of numerical results and focus more on interpretation

• Integrate limitations into the final paragraph of the Discussion, without a separate subheading

___________________________________________________________________

Strengths and limitations

Reviewer comment: Limitations related to routine laboratory data quality and lack of spatial visualisation are not sufficiently acknowledged.

Authours’ response: These limitations are now explicitly acknowledged in the final paragraph of the Discussion, including data incompleteness, potential duplicate submissions, absence of herd-level metadata, and limited spatial modelling. Capitalisation and sentence structure have also been corrected.

___________________________________________________________________

Conclusion

Reviewer comment: Some statements imply causality and should be presented more cautiously.

Authours’ response: The Conclusion has been revised to avoid causal language and to emphasise that findings represent associations from a retrospective observational study. Seasonal and spatial interpretations are now more cautious and aligned with the analytical evidence.

___________________________________________________________________

References

Reviewer comment: Several references are outdated, incomplete, or incorrect.

Authours’ response: The reference list has been thoroughly reviewed. Incorrect or unverifiable references have been corrected or removed, DOIs updated where available, and recent literature prioritised to ensure accuracy and relevance.

___________________________________________________________________

Attachment

Submitted filename: Response to reviewers.docx

pone.0344037.s002.docx (17.1KB, docx)

Decision Letter 1

Mabel Aworh

1 Feb 2026

Dear Dr. Sigudu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 18 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Mabel Kamweli Aworh, DVM, MPH, PhD. FCVSN

Academic Editor

PLOS One

Journal Requirements:

1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with 2. relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

In addition to addressing all reviewer comments, please ensure that line numbers are included throughout the revised manuscript to facilitate the review process.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

Reviewer #1: References are important in research as they provide evidence, facilitate the exploration of various sources, and establish credibility within the academic community. However, the comments regarding the reference section in the initial review were overlooked. Therefore, I recommend minor revisions to address these issues.

Reviewer #2: The authors should be commended for their thorough and constructive engagement with reviewer feedback. The revised manuscript demonstrates substantial improvement across all previously identified areas of concern.

Key improvements since the previous round include:

Explicit definition of dependent and independent variables and reference categories

Clear justification for batch-level analysis and the inability to perform multilevel modelling

Appropriate use of univariate and multivariable logistic regression

Reporting of model diagnostics (Hosmer–Lemeshow test and AUC)

Explicit discussion of collinearity, correlated predictors, and unequal seasonal sample sizes

The revised interpretation of seasonal effects particularly the attenuation and direction change after adjustment is now statistically sound and carefully explained.

The Methods section is now comprehensive and reproducible, with clear variable definitions, data cleaning procedures, and modelling decisions.

Statistical inconsistencies identified in the previous round have been corrected, and interpretations are now aligned with the final model specification.

The addition of a choropleth map appropriately complements the tabular spatial analysis and supports descriptive claims without overstating inference.

The Discussion and Conclusion have been carefully revised to avoid causal language and speculative claims, with limitations clearly acknowledged and integrated. The conclusions are well supported by the data and are framed cautiously as associations rather than causal effects. Claims regarding temporal trends, seasonal variability, and spatial heterogeneity are consistent with the descriptive and regression results presented. Overinterpretation has been avoided, particularly with respect to seasonal drivers and spatial “hotspots.”

Overall, the manuscript now provides a robust, transparent, and policy-relevant epidemiological description of bovine brucellosis patterns in Mpumalanga Province and represents a valuable contribution to the literature on routine surveillance data use in endemic settings.

I have no further substantive comments and support publication.

Reviewer #3: The authors have made meaningful progress in addressing the major concerns raised in the initial review. Methodological transparency has improved, with clearer variable definitions, data preprocessing descriptions, and more consistent reporting of logistic regression results. Internal inconsistencies between tables and text have largely been resolved, and statistical interpretations are now clearer and more accurate.

The inclusion of spatial visualization strengthens the presentation of geographic patterns, although claims regarding spatial “hotspots” remain appropriately cautious given the absence of formal spatial modelling. The Discussion and Conclusions are better aligned with the corrected results and more clearly distinguish observed associations from speculative explanations.

Additional Comments

Reference formatting and numbering: Reference formatting remains inconsistent. Citations are not numbered and ordered consistently in accordance with their first appearance in the text, and several in-text citations do not clearly correspond to the reference list. The authors should carefully renumber all references sequentially, ensure one-to-one correspondence between in-text citations and the reference list, and confirm that all references adhere strictly to the journal’s formatting requirements.

Several cited sources appear to predate the last five years. The authors should ensure that the majority of references reflect recent literature and clearly justify the inclusion of older sources.

Strengths and limitations: The manuscript does not include a clearly outlined Strengths and Limitations section. Given the nature of the data and study design, a dedicated subsection is necessary to explicitly summarize methodological strengths and key limitations. This section would improve transparency and aid interpretation of the findings.

Overall, the manuscript now represents a substantially improved and policy-relevant contribution and is suitable for publication pending minor revision.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Mar 6;21(3):e0344037. doi: 10.1371/journal.pone.0344037.r005

Author response to Decision Letter 2


9 Feb 2026

Response to Reviewers

We sincerely thank the Editor and the reviewers for their careful evaluation of the manuscript and for their constructive comments. We appreciate the positive assessment of the revised version and have addressed the remaining minor issues as requested. All changes have been incorporated into the manuscript, and the reference list has been thoroughly revised.

Reviewer 1

Comment: References are important in research as they provide evidence, facilitate exploration of sources, and establish credibility. However, the comments regarding the reference section in the initial review were overlooked. Minor revisions are recommended to address these issues.

Response: We thank the reviewer for highlighting the importance of the reference section. The references have now been comprehensively revised to ensure full compliance with the journal’s formatting and citation requirements.

Revisions made:

• All references have been renumbered sequentially according to their first appearance in the text.

• In-text citations have been cross-checked to ensure one-to-one correspondence with the reference list.

• Formatting has been standardised to the journal’s required style.

• Recent literature has been prioritised where available, while older foundational references have been retained only where necessary for historical or methodological context.

Reviewer 2

Comment: The reviewer commends the substantial improvements and supports publication, with no further substantive comments.

Response: We thank the reviewer for the positive evaluation of the revised manuscript and for acknowledging the improvements in methodological transparency, statistical reporting, and interpretation. No further changes were required in response to this review.

Reviewer 3

Comment 1: Reference formatting and numbering - Reference formatting remains inconsistent. Citations are not numbered and ordered consistently, and some in-text citations do not correspond clearly to the reference list. The authors should renumber all references sequentially and ensure formatting compliance.

Response: We appreciate this observation and have performed a full audit of the reference section.

Revisions made:

• All references were renumbered in sequential order according to first citation.

• In-text citations were cross-checked line by line against the reference list.

• Duplicate, mismatched, or unclear citations were corrected.

• Formatting was standardised according to the journal’s reference style.

Comment 2: Use of recent literature - Several cited sources appear to predate the last five years. The authors should ensure that the majority of references reflect recent literature and justify older sources.

Response: We have updated the reference list to improve representation of recent literature.

Revisions made:

Recent studies (2020–2024) were incorporated where relevant, particularly for:

• One Health frameworks

• Surveillance strategies

• Spatial epidemiology

• Control programme evaluations

• Older references were retained only where they represent:

• Foundational epidemiological evidence

• Key diagnostic or control programme references

• Legislative or policy sources

Comment 3: Strengths and limitations section - The manuscript lacks a clearly outlined Strengths and Limitations section. A dedicated subsection is required.

Response: We agree with the reviewer. A new subsection titled “Strengths and Limitations” has been added to the Discussion to improve transparency and interpretation.

Attachment

Submitted filename: Response to Reviewer revised.docx

pone.0344037.s003.docx (15.5KB, docx)

Decision Letter 2

Mabel Aworh

10 Feb 2026

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 27 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Mabel Kamweli Aworh, DVM, MPH, PhD. FCVSN

Academic Editor

PLOS One

Journal Requirements:

1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Please remove all subheadings from the Discussion section, including “Strengths and Limitations of the Study.” The study limitations should be presented as the final paragraph of the Discussion.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Mar 6;21(3):e0344037. doi: 10.1371/journal.pone.0344037.r007

Author response to Decision Letter 3


11 Feb 2026

Dear Editor,

We thank you for the careful evaluation of our manuscript and for the constructive guidance provided. We have addressed all journal and editorial requirements and revised the manuscript accordingly. A detailed, point-by-point response is provided below.

Journal Requirement 1

Comment: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited.

Response: We carefully reviewed all reviewer comments and evaluated the relevance of any suggested references. Where suggested works were directly relevant to the scope, methodology, or interpretation of our findings, they were incorporated into the manuscript. References that were not directly relevant were not included, in accordance with the journal’s guidance that citation of suggested works is not mandatory unless instructed by the editor.

Journal Requirement 2

Comment: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so or remove them.

Response: The entire reference list was carefully reviewed to ensure:

• Accuracy of bibliographic information

• Correct and functional DOIs

• Consistency with journal formatting

• Relevance to the manuscript

A check was conducted to identify any retracted publications. No retracted articles were identified in the reference list. Therefore, no references were removed or replaced on the basis of retraction, and no additional explanatory statements were required in the manuscript. Minor corrections to reference formatting and consistency were implemented where necessary. These changes are reflected in the revised manuscript.

Additional Editor Comment

Comment: Please remove all subheadings from the Discussion section, including “Strengths and Limitations of the Study.” The study limitations should be presented as the final paragraph of the Discussion.

Response: We have revised the Discussion section as requested:

• All subheadings have been removed from the Discussion section, including the subheading “Strengths and limitations of the study.”

• The content previously presented under this subheading has been integrated into the main Discussion text. The study limitations are now presented as the final paragraph of the Discussion, in narrative form.

Attachment

Submitted filename: Rebuttal letter 120226.docx

pone.0344037.s004.docx (14.5KB, docx)

Decision Letter 3

Mabel Aworh

15 Feb 2026

Bovine Brucellosis Seropositivity in Mpumalanga Province, South Africa, 2021–2024: Temporal, and Spatial Trends

PONE-D-25-59216R3

Dear Dr. Sigudu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mabel Kamweli Aworh, DVM, MPH, PhD. FCVSN

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Mabel Aworh

PONE-D-25-59216R3

PLOS One

Dear Dr. Sigudu,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Mabel Kamweli Aworh

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0344037.s002.docx (17.1KB, docx)
    Attachment

    Submitted filename: Response to Reviewer revised.docx

    pone.0344037.s003.docx (15.5KB, docx)
    Attachment

    Submitted filename: Rebuttal letter 120226.docx

    pone.0344037.s004.docx (14.5KB, docx)

    Data Availability Statement

    Aggregated, de-identified data at LMA level and all analysis code are openly available at Zenodo (DOI: 10.5281/zenodo.1234567). The underlying farm-level microdata are held by the Mpumalanga Department of Agriculture, Rural Development, Land and Environmental Affairs (DARDLEA) and include potentially identifying and commercially/confidential information. Public release is restricted under South Africa’s Promotion of Access to Information Act (PAIA) and Protection of Personal Information Act (POPIA). Qualified researchers may request access from the DARDLEA Information Officer under PAIA, subject to a data-sharing agreement and approvals. The authors had no special access privileges others would not have. Contact: Email (PAIA office): DardleaPaia@mpg.gov.za dardlea.mpg.gov.za PAIA manual (URL): https://dardlea.mpg.gov.za/documents/PAIA_Manual.pdf.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES